<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696368</url>
  </required_header>
  <id_info>
    <org_study_id>1808964513</org_study_id>
    <nct_id>NCT03696368</nct_id>
  </id_info>
  <brief_title>The Hoosier Moms Cohort</brief_title>
  <official_title>Understanding Diverse Contributors to Gestational Diabetes Mellitus and Its Near-to-Long Term Consequences: An Indiana University Grand Challenges Precision Health Initiative Cohort Study (The Hoosier Moms Cohort)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Hoosier Moms Cohort (HMC) study's goal is to better understand the pathophysiology&#xD;
      underlying the development of gestational diabetes mellitus (GDM) in pregnant women and its&#xD;
      transition to Type 2 diabetes mellitus in mothers and their exposed children.&#xD;
&#xD;
      The HMC study wants to determine what biomarkers (genetic, blood based and&#xD;
      behavioral/interventional) can be identified in pregnant women affected with GDM and how&#xD;
      those biomarkers can be used to impact preventative care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Predictive GDM genetic risk models will be tested and refined in the Hoosier Moms Cohort. In&#xD;
      addition to prospectively using genetic information to predict GDM risk, the Hoosier Moms&#xD;
      Cohort will incorporate the use of wearable/digital devices for collection of detailed&#xD;
      behavioral information, support development of novel dietary capture methods, and enable the&#xD;
      collection of specimens specifically aimed at multiple 'omics' techniques to engage in a&#xD;
      detailed, multidimensional assessment of pathophysiologic pathways and biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2019</start_date>
  <completion_date type="Anticipated">November 2025</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>GDM Diagnosis</measure>
    <time_frame>42 weeks or less gestational age</time_frame>
    <description>Number of subjects diagnosed with GDM</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Gestational Diabetes</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  Maternal blood&#xD;
&#xD;
        -  Maternal urine&#xD;
&#xD;
        -  Maternal stool&#xD;
&#xD;
        -  Cord blood&#xD;
&#xD;
        -  Infant buccal swab&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        500 pregnant women with an enhanced risk of GDM will be recruited from obstetrical clinics&#xD;
        associated with the Indiana University School of Medicine or by self referral.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Singleton gestation&#xD;
&#xD;
          -  Gestational age â‰¤ 20+0 confirmed via American Congress of Obstetrics and Gynecology&#xD;
             (ACOG) ultrasound dating guidelines&#xD;
&#xD;
          -  18 years old or greater at time of consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre pregnancy diagnosis of Type 1 Diabetes or Type 2 Diabetes or Screening Hemoglobin&#xD;
             A1C that is greater than or equal to 6.5% or two abnormal values on a 3 hours Oral&#xD;
             Glucose Tolerance Test (100g load) before 20 weeks gestation&#xD;
&#xD;
          -  Pre pregnancy chronic usage of systemic steroids (inhaled and short term usage&#xD;
             acceptable)&#xD;
&#xD;
          -  Planned pregnancy termination&#xD;
&#xD;
          -  Unable to provide informed consent in English or Spanish&#xD;
&#xD;
          -  Major fetal anomalies as listed below that are known prior to enrollment. If these are&#xD;
             discovered after enrollment, the participant may be allowed to participate, unless the&#xD;
             discovered fetal anomaly is a lethal anomaly.&#xD;
&#xD;
        Major Fetal Anomalies to be Excluded:&#xD;
&#xD;
          -  Congenital diaphragmatic hernia&#xD;
&#xD;
          -  Congenital cystic adenomatoid malformation&#xD;
&#xD;
          -  Pleural effusions&#xD;
&#xD;
          -  Chylothorax&#xD;
&#xD;
          -  Bronchogenic cyst&#xD;
&#xD;
          -  Bronchopulmonary sequestration&#xD;
&#xD;
          -  Anomalous pulmonary venous return&#xD;
&#xD;
          -  Tricuspid atresia&#xD;
&#xD;
          -  Mitral atresia&#xD;
&#xD;
          -  Double right ventricle&#xD;
&#xD;
          -  Ebstein's malformation&#xD;
&#xD;
          -  Pulmonary atresia&#xD;
&#xD;
          -  Hypoplastic left heart syndrome&#xD;
&#xD;
          -  Aortic coarctation&#xD;
&#xD;
          -  Fetal arrhythmias (tachycardia or bradycardia)&#xD;
&#xD;
          -  Transposition of the great vessels&#xD;
&#xD;
          -  Tetrology of Fallot&#xD;
&#xD;
          -  Double outlet right ventricle&#xD;
&#xD;
          -  Aortic stenosis&#xD;
&#xD;
          -  Holoprosencephaly&#xD;
&#xD;
          -  Anencephaly&#xD;
&#xD;
          -  Dandy-Walker malformation or variant&#xD;
&#xD;
          -  Septo-optic dysplasia&#xD;
&#xD;
          -  Neural tube defect&#xD;
&#xD;
          -  Vein of Galen aneurysm&#xD;
&#xD;
          -  Bilateral renal agenesis&#xD;
&#xD;
          -  Cystic renal disease (polycystic or multicystic)&#xD;
&#xD;
          -  Any genitourinary lesion accompanied by oligohydramnios at &lt;24 weeks&#xD;
&#xD;
          -  Obstructive uropathy&#xD;
&#xD;
          -  Horseshoe kidney&#xD;
&#xD;
          -  Megacystis microcolon&#xD;
&#xD;
          -  Achondrogenesis&#xD;
&#xD;
          -  Thanatophoric dysplasia&#xD;
&#xD;
          -  Thoracic dysplasia&#xD;
&#xD;
          -  Osteogenesis imperfect&#xD;
&#xD;
          -  Short rib polydactyly&#xD;
&#xD;
          -  Any skeletal defect associated with small thorax&#xD;
&#xD;
          -  Hypophosphatemia&#xD;
&#xD;
          -  Any karyotypic abnormality&#xD;
&#xD;
          -  Any suspected genetic syndrome&#xD;
&#xD;
          -  Cleft lip/palate&#xD;
&#xD;
          -  Micrognathia&#xD;
&#xD;
          -  Hydrops&#xD;
&#xD;
          -  Fetal anemia (&lt;35% on cordocentesis)&#xD;
&#xD;
          -  Neck mass&#xD;
&#xD;
          -  Gastroschisis&#xD;
&#xD;
          -  Omphalocele&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David M Haas, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David M Haas, MD, MS</last_name>
    <phone>317-880-3960</phone>
    <email>dahaas@iu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathleen M Flannery, BS</last_name>
    <phone>317-880-3961</phone>
    <email>kamaflan@iu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IU Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Flannery, BS</last_name>
      <phone>317-880-3961</phone>
      <email>kamaflan@iu.edu</email>
    </contact>
    <investigator>
      <last_name>David M Haas, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IUH Coleman Center for Women</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen M Flannery</last_name>
      <phone>317-880-3961</phone>
      <email>kamaflan@iu.edu</email>
    </contact>
    <investigator>
      <last_name>David M Haas, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IUH Prenatal Diagnosis Clinic</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen M Flannery</last_name>
      <phone>317-880-3961</phone>
      <email>kamaflan@iu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sidney and Lois Eskenazi Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Flannery, BS</last_name>
      <phone>317-880-3961</phone>
      <email>kamaflan@iu.edu</email>
    </contact>
    <investigator>
      <last_name>David M Haas, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tri-state Perinatology at The Women's Hospital</name>
      <address>
        <city>Newburgh</city>
        <state>Indiana</state>
        <zip>47630</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Goffinet, RN, BSN</last_name>
      <phone>812-474-7184</phone>
    </contact>
    <investigator>
      <last_name>Contantine Scordalakes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Health Care PC</name>
      <address>
        <city>Newburgh</city>
        <state>Indiana</state>
        <zip>47630</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Goffinet, RN, BSN</last_name>
      <phone>812-474-7184</phone>
    </contact>
    <investigator>
      <last_name>Constantine Scordalakes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 3, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>David Haas</investigator_full_name>
    <investigator_title>Professor of Obstetrics &amp; Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

